The A-share influenza sector fluctuated and weakened, with Teyi Pharmaceutical hitting the daily limit down. Jiaying Pharmaceutical had previously hit the daily limit down, and other companies such as Zhong Sheng Pharmaceutical, Dana Biotechnology, Asia Pacific Pharmaceutical, Panlong Pharmaceutical, and Tailong Pharmaceutical followed suit.